Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · IEX Real-Time Price · USD
0.238
-0.022 (-8.56%)
At close: Jul 19, 2024, 4:00 PM
0.232
-0.007 (-2.73%)
Pre-market: Jul 22, 2024, 7:43 AM EDT
Conduit Pharmaceuticals Statistics
Total Valuation
CDT has a market cap or net worth of $17.58 million. The enterprise value is $17.03 million.
Market Cap | 17.58M |
Enterprise Value | 17.03M |
Important Dates
The next estimated earnings date is Tuesday, August 13, 2024, before market open.
Earnings Date | Aug 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CDT has 73.83 million shares outstanding. The number of shares has increased by 14.24% in one year.
Shares Outstanding | 73.83M |
Shares Change (YoY) | +14.24% |
Shares Change (QoQ) | -1.71% |
Owned by Insiders (%) | 86.00% |
Owned by Institutions (%) | 0.69% |
Float | 18.45M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.59
Current Ratio | 1.59 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.05 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -38.00% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$327,857 |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 1.89 |
200-Day Moving Average | 2.81 |
Relative Strength Index (RSI) | 11.82 |
Average Volume (20 Days) | 7,696,699 |
Short Selling Information
The latest short interest is 73,075, so 0.10% of the outstanding shares have been sold short.
Short Interest | 73,075 |
Short Previous Month | 56,774 |
Short % of Shares Out | 0.10% |
Short % of Float | 0.40% |
Short Ratio (days to cover) | 1.03 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -6.64M |
Pretax Income | -2.30M |
Net Income | -2.30M |
EBITDA | -2.01M |
EBIT | -2.01M |
Earnings Per Share (EPS) | -$7,310.98 |
Balance Sheet
The company has $1.84 million in cash and $1.30 million in debt, giving a net cash position of $549,000 or $0.01 per share.
Cash & Cash Equivalents | 1.84M |
Total Debt | 1.30M |
Net Cash | 549,000 |
Net Cash Per Share | $0.01 |
Equity (Book Value) | -3.10M |
Book Value Per Share | -0.04 |
Working Capital | 1.17M |
Cash Flow
Operating Cash Flow | -8.11M |
Capital Expenditures | n/a |
Free Cash Flow | -8.11M |
FCF Per Share | -$0.11 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CDT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -14.24% |
Shareholder Yield | -14.24% |
Earnings Yield | -13.06% |
FCF Yield | -46.15% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |